Equities

Multi Medika Internasional PT Tbk

MMIX:JKT

Multi Medika Internasional PT Tbk

Actions
Health CareMedical Equipment and Services
  • Price (IDR)51.00
  • Today's Change-2.00 / -3.77%
  • Shares traded2.46m
  • 1 Year change-85.83%
  • Beta--
Data delayed at least 10 minutes, as of May 08 2024 10:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Multi Medika Internasional Tbk is an Indonesia-based company, which is engaged in wholesale trading of laboratory equipment, pharmaceutical equipment and medical devices for humans, leasing intellectual property without option rights-not copyrights, management consulting activities, wholesale cosmetics, courier agency activities, Web portals and/or digital platforms for commercial purposes and wholesale trade of various goods and other household goods. Its MIU MASK Product is a practical and waterproof multifunctional daily mask, made of three layers of Non-Woven and Melt blown. Its product variants in MIU MASK include Double Mask Protection, Duckbill Mask Foldmed, Duckbill Mask REMOVAX and others. Its MIU health care products include hazmat suit, surgical gown, antigen kit, oximeter and others. It offers face masks under the INDOMARET brand. It also offers face masks under the ALFAMART ALFAMIDI brand. Its Justice League brand offers face masks and aromatherapy.

  • Revenue in IDR (TTM)175.13bn
  • Net income in IDR16.51bn
  • Incorporated--
  • Employees112.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Truscreen Group Ltd18.36bn-24.44bn95.77bn----6.40--5.22-0.0062-0.00620.00470.00280.76012.1513.96---101.14-49.88-141.88-55.1423.8429.45-133.08-293.271.71--0.00---0.944315.6469.57--74.07--
Opto Circuits (India) Ltd209.34bn-246.88bn104.37bn1.84k------0.4986-4.27-4.273.83-------------14.78---30.0853.6252.13-126.79-151.05---0.7372-----29.10-31.34-2,762.41------
China Regenerative Medicine Intl Ltd142.55bn-220.93bn120.46bn46.00--4.98--0.8451-0.376-0.3760.24320.03880.3009136.97109.691,510,587.00-46.64-25.53-138.21-49.2627.9521.79-154.99-66.501.14-110.070.8097---70.00-0.9685-2,464.41---53.94--
Multi Medika Internasional PT Tbk175.13bn16.51bn127.20bn112.0029.530.70885.920.72631.791.79101.3574.78------1,563,700,000.00--------59.88--9.43--1.225.990.419--0.0232---30.23------
Dentas Co Ltd85.85bn-5.38bn127.32bn47.00------1.48-127.50-127.502,035.329.361.323.736.0517,610,720.00-8.50-8.25-15.28-14.2327.8528.71-6.44-5.700.816-10.000.9371--28.985.86-7.68---28.27--
Adherium Ltd42.87bn-92.16bn131.37bn----1.28--3.06-0.0252-0.02520.01170.01320.35840.98752.83---77.05-119.77-98.58-166.8468.5144.60-214.98-408.702.16--0.0045--50.87-3.991.85---39.21--
Data as of May 08 2024. Currency figures normalised to Multi Medika Internasional PT Tbk's reporting currency: Indonesian Rupiah IDR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.